BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Following the FDA's introduction of the Modernization Act 3.0 
 and the latest guidance on new approach methods (NAMs)\, GSK developing a
  new lung organoid model to empower pulmonary fibrosis research\, and Mer
 ck acquiring HUB Organoids to enable more effective drug development and 
 reduce reliance on animal testing\, it's an exciting time for pharma and 
 biotech to leverage complex in vitro models in drug discovery and develop
 ment.\n\nDespite this growth\, challenges persist in standardizing protoc
 ols for model validation\, safeguarding model reproducibility while ensur
 ing scalability\, and understanding what data regulators will accept.\n\n
 Built by biopharma-for-biopharma\, the 10th 3D Tissue Models Summit retur
 ns to unite 'front-line' experts to share practical case studies on valid
 ating\, improving reproducibility\, and interrogating regulatory requirem
 ents for complex in vitro models in drug discovery and development.\n\nJo
 in the only intimate\, industry-focussed forum to stay abreast on how to 
 confidently harness various complex in vitro models to transform your own
  discovery and development workflows and empower clinical translatability
 .\n\nDate and Time: Tuesday\, 06 May 2025 at 09:00 to Thursday\, 08 May 2
 025 at 15:15\n
DTEND:20250508T151500
DTSTAMP:20260514T145931Z
DTSTART:20250506T090000
LOCATION:Hilton Boston Back Bay\, 40 Dalton Street\, Boston\, Massachusett
 s\, 02115\,
SEQUENCE:0
SUMMARY:Following the FDA's introduction of the Modernization Act 3.0 and 
 the latest guidance on new approach methods (NAMs)\, GSK developing a new
  lung org...
UID:f2e3430c-7d16-452b-8134-7cf4c6e96b82
END:VEVENT
END:VCALENDAR